| dc.contributor.author | Giles, Y | |
| dc.contributor.author | Tezelman, S | |
| dc.contributor.author | Kapran, Y | |
| dc.contributor.author | Terzioglu, T | |
| dc.contributor.author | Aksoy, M | |
| dc.date.accessioned | 2021-03-04T13:10:47Z | |
| dc.date.available | 2021-03-04T13:10:47Z | |
| dc.date.issued | 2005 | |
| dc.identifier.citation | Aksoy M., Giles Y., Kapran Y., Terzioglu T., Tezelman S., "Expression of bcl-2 in papillary thyroid cancers and its prognostic value", ACTA CHIRURGICA BELGICA, cilt.105, sa.6, ss.644-648, 2005 | |
| dc.identifier.issn | 0001-5458 | |
| dc.identifier.other | av_7b03fac8-5283-4da1-986e-caff063979d3 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/84242 | |
| dc.identifier.uri | https://doi.org/10.1080/00015458.2005.11679794 | |
| dc.description.abstract | Purpose : Papillary thyroid cancer has a good prognosis. This favourable prognosis may be attributed to the apoptotic tendency of the cancer cells. This study aims to evaluate the expression of bcl-2, which is an antidote of apoptosis, and aims to evaluate the value of bcl-2 as a prognostic marker in papillary thyroid cancer. | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | CERRAHİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Tıp | |
| dc.subject | Cerrahi Tıp Bilimleri | |
| dc.title | Expression of bcl-2 in papillary thyroid cancers and its prognostic value | |
| dc.type | Makale | |
| dc.relation.journal | ACTA CHIRURGICA BELGICA | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 105 | |
| dc.identifier.issue | 6 | |
| dc.identifier.startpage | 644 | |
| dc.identifier.endpage | 648 | |
| dc.contributor.firstauthorID | 176742 | |